EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Altered Vascular and Angiogenic Transcripts in the Neurogenic Niche in Neuroinflammatory-Type Schizophrenia

Hayley F North iD, Jessica Lim, Janice M Fullerton, Maree J Webster, Cynthia Shannon Weickert iD

Schizophrenia Bulletin · 2026

DOI: 10.1093/schbul/sbaf177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Bulletin, 2026. Verfasst von Hayley F North und 4 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, …. Hauptthemen laut MEDLINE: Schizophrenia, Claudin-5, Blood-Brain Barrier, RNA, Messenger. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NSW Health Schizophrenia Research, NIAAA NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis Growing evidence indicates that vascular processes, including blood–brain barrier (BBB) function and angiogenesis, may be altered in schizophrenia and related to neuroinflammation. The subependymal zone (SEZ) neurogenic niche shows reduced neurogenesis markers in schizophrenia that are more pronounced with neuroinflammation. Since inflammatory neuropathology is related to increased diapedesis-related transcripts, we hypothesize that endothelial cells would be impacted in this neurogenic niche in schizophrenia. Study Design We measured the expression of four BBB-related mRNAs [claudin-5 (CLDN5), occludin (OCLN), platelet endothelial cell adhesion molecule-1 (PECAM1), and tight junction protein 1 (TJP1)] and five angiogenesis-related mRNAs [angiopoietin 1 (ANGPT1), angiopoietin 2 (ANGPT2), vascular endothelial growth factor A (VEGFA), vascular endothelial growth factor receptor 1 (VEGFR1), and TEK receptor tyrosine kinase (TEK)] via quantitative polymerase chain reaction, followed by semi-quantitative immunofluorescence for claudin-5 and collagen-IV protein. We estimated proportions of vascular cells by running cellular deconvolution on previous bulk RNA sequencing data. Study Results In high-inflammation schizophrenia, we found increased PECAM1 mRNA, CLDN5 mRNA and claudin-5 protein expression potentially relating to leukocyte trafficking and repair of endothelial tight junctions. The estimated proportion of vascular cells and VEGFA mRNA levels were increased, potentially indicating increased angiogenesis in high-inflammation schizophrenia. Higher VEGFA and CLDN5 mRNA levels were associated with higher expression of markers of immune cell transmigration but lower expression of immature neuron markers, suggesting that vascular dysfunction may impact neurogenesis. Conclusions These findings reveal that changes in the BBB and angiogenesis are more severe in high-inflammation schizophrenia and appear to be linked to reduced neurogenesis in the SEZ. This study underscores the importance of inflammation in shaping vascular and neurogenic pathology in schizophrenia, offering potential pathways for future therapeutic exploration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaClaudin-5Blood-Brain BarrierRNA, MessengerNeuroinflammatory DiseasesAngiogenesisNeurogenesisEndothelial CellsHumansFemaleMaleVascular Endothelial Growth Factor APlatelet Endothelial Cell Adhesion Molecule-1OccludinZonula Occludens-1 ProteinAdultAngiopoietin-2Vascular Endothelial Growth Factor Receptor-1Angiopoietin-1Middle Aged

Stichwörter der Autor:innen

Schizophreniaangiogenesisblood brain barrierclaudin-5inflammationneurogenesis

Substanzen

Claudin-5RNA, MessengerVascular Endothelial Growth Factor APlatelet Endothelial Cell Adhesion Molecule-1CLDN5 protein, humanOccludinZonula Occludens-1 ProteinOCLN protein, humanPECAM1 protein, humanTJP1 protein, human

Autor:innen und Institutionen

  • Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
  • Schizophrenia Research Laboratory, Neuroscience Research Australia, Randwick, NSW, Australia.
  • School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW Australia.
  • Laboratory of Brain Research, Stanley Medical Research Institute, 9800 Medical Center Drive, Rockville, MD United States.
  • Department of Neuroscience & Physiology, Upstate Medical University, 505 Irving Ave, Syracuse, NY 13210, United States.

ORCID-Profile: Hayley F North, Cynthia Shannon Weickert

Förderung

  • NSW Health Schizophrenia Research
  • NIAAA NIH HHS
  • NIMH NIH HHS
  • NHMRC Medical Research Futures
  • National Health and Medical Research Council
  • NIH RO1 grant "Neuroinflammation and Neurogenesis in Schizophrenia"
  • NIH RO1 grant “Neuroinflammation and Neurogenesis in Schizophrenia”

Zitieren

APA

North, H. F., Lim, J., Fullerton, J. M., Webster, M. J., & Shannon Weickert, C. (2026). Altered Vascular and Angiogenic Transcripts in the Neurogenic Niche in Neuroinflammatory-Type Schizophrenia. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbaf177

Vancouver

North HF, Lim J, Fullerton JM, Webster MJ, Shannon Weickert C. Altered Vascular and Angiogenic Transcripts in the Neurogenic Niche in Neuroinflammatory-Type Schizophrenia. Schizophrenia Bulletin. 2026. doi:10.1093/schbul/sbaf177

BibTeX
@article{North2026,
  author = {North, Hayley F and Lim, Jessica and Fullerton, Janice M and Webster, Maree J and Shannon Weickert, Cynthia},
  title = {Altered Vascular and Angiogenic Transcripts in the Neurogenic Niche in Neuroinflammatory-Type Schizophrenia},
  journal = {Schizophrenia Bulletin},
  year = {2026},
  doi = {10.1093/schbul/sbaf177}
}
Kostenlos starten →